ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IDXG vs DE // ALTMAN Z-SCORE & DEBT/EQUITY

Interpace Biosciences Inc. (NASDAQ) VS. Deere & Company (NYSE) • 15-METRIC TALLY: IDXG 4 — DE 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IDXG VS. DE) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IDXG DE SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 16.20% 9.30% +6.90 IDXG /roic <GO>
EV/EBITDA & P/E Valuation 4.7x 27.9x -23.20 IDXG /valuation <GO>
Free Cash Flow Yield 23.60% 3.43% +20.17 IDXG /fcf-yield <GO>
Operating Margin 10.50% 13.40% -2.90 DE /operating-margins <GO>
Net Profit Margin 63.50% 11.00% +52.50 IDXG /net-margins <GO>
Revenue Growth (YoY) -17.50% -11.70% -5.80 DE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.97% -0.97 DE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 3.00 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 6/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.5 52.5 -1.00 DE /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.95 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 32.9x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $23.2M $177.95B -$177.93B DE /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IDXG REV DE REV IDXG GROSS % DE GROSS % IDXG FCF DE FCF
FY 2025 $38.7M $45.68B 62.3% — $5.5M $6.10B
FY 2024 $46.9M $51.72B 63.8% — $3.8M $7.59B
FY 2023 $40.0M $61.25B — — $3.8M $5.83B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IDXG // BETA —
DE // BETA 0.95